Millipore Sigma Vibrant Logo

555552 InSolution™ Rho Kinase Inhibitor - Calbiochem

View Products on Sigmaaldrich.com
555552
가격 및 재고 조회

개요

Replacement Information

주요 사양표

Empirical Formula
C₁₆H₂₁N₃O₂S • 2HCl

가격 및 재고여부

카탈로그 번호 재고 정보패킹 포장 단위 가격(VAT 별도) 수량
555552-500UGCN
재고 정보 검색...
현재 재고 없음
현재 재고 없음
예상 출고 가능일 
단종품
제한된 수량 가능
재고여부 확인
    Remaining: will advise
      Remaining: will advise
      추천사항
      고객 서비스로 문의
      Contact Customer Service

      Plastic ampoule 500 μg
      가격 검색...
      가격을 검색할 수 없습니다
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      가격 문의 추가 정보
      ()이 할인됨
       
      가격 문의
      Description
      Catalogue Number555552
      Brand Family Calbiochem®
      References
      ReferencesIkenoya, M., et al. 2002. J. Neurochem. 81, 9.
      Sasaki, Y., et al. 2002. Pharmacol. Ther. 93, 225.
      Product Information
      ATP CompetitiveY
      FormLiquid
      FormulationA 10 mM (500 µg/128 µl) solution of Rho Kinase Inhibitor (Cat. No. 555550) in H₂O.
      Hill FormulaC₁₆H₂₁N₃O₂S • 2HCl
      Chemical formulaC₁₆H₂₁N₃O₂S • 2HCl
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetROCK
      Primary Target K<sub>i</sub>1.6 nM against Rho-associated kinase (ROCK)
      Purity≥95% by HPLC
      Concentration Label Please refer to vial label for lot-specific concentration
      Physicochemical Information
      Cell permeableN
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Blue Ice Only
      Toxicity Harmful
      Storage -20°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-20°C).
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      카탈로그 번호 GTIN
      555552-500UGCN 04055977268423

      Documentation

      InSolution™ Rho Kinase Inhibitor - Calbiochem MSDS

      타이틀

      물질안전보건자료(MSDS) 

      InSolution™ Rho Kinase Inhibitor - Calbiochem Certificates of Analysis

      TitleLot Number
      555552

      References

      참고문헌 보기
      Ikenoya, M., et al. 2002. J. Neurochem. 81, 9.
      Sasaki, Y., et al. 2002. Pharmacol. Ther. 93, 225.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision09-September-2008 RFH
      DescriptionA cell-permeable isoquinolinesulfonamide compound that acts as a highly specific, potent, and ATP-competitive inhibitor of G-protein Rho-associated kinase (ROCK; Ki = 1.6 nM). Inhibits other serine/threonine kinases only at higher concentrations (Ki = 630 nM for PKA, 9.27 µM for PKC, and 10.1 µM for MLCK). Shown to selectively block lysophosphatidic acid-induced, but not PDBu-induced, phosphorylation of myristoylated alanine-rich C kinase substrate (MARCKS) in NT-2 cells (IC50 = 2.5 µM). Reported to be a more potent and selective inhibitor than Y-27632 (Cat. No. 688000 & 688001).
      FormLiquid
      FormulationA 10 mM (500 µg/128 µl) solution of Rho Kinase Inhibitor (Cat. No. 555550) in H₂O.
      Intert gas (Yes/No) Packaged under inert gas
      Concentration Label Please refer to vial label for lot-specific concentration
      Chemical formulaC₁₆H₂₁N₃O₂S • 2HCl
      Structure formulaStructure formula
      Purity≥95% by HPLC
      Storage Protect from light
      -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-20°C).
      Toxicity Harmful
      ReferencesIkenoya, M., et al. 2002. J. Neurochem. 81, 9.
      Sasaki, Y., et al. 2002. Pharmacol. Ther. 93, 225.